Diaphragm Sparing Effect of Subomohyoid Block With Infraclavicular or Subscapularis Blocks in Comparison With Interscalen Block for Postoperative Analgesia in Shoulder Surgeries

December 26, 2025 updated by: Emad Hamdy Mohamed Morsy, Zagazig University

The gold standard for shoulder analgesia is the interscalene block (ISB), but it has its own share of disadvantages such as phrenic nerve block, recurrent laryngeal nerve involvement and Horner's syndrome may lead to patient discomfort .Others, such as intrathecal spread and systemic toxicity of local anesthetic, can have serious consequences.

Phrenic nerve injury is a common complication with regional anesthesia. Its either temporary with Transient Phrenic Nerve Palsy leading to hemidiaphragmatic paresis after interscalene block or other injections of local anesthetic in the neck .

Although studies of ISB have shown a reduction in the incidence in hemidiaphragmatic paralysis with low-volume ISB, the risk of phrenic paralysis is not completely eliminated.

To bypass this complication, distal block of the shoulder innervation is recommended such as subomohyoid infraclavicular and subomohyoid subscapularis blocks.

Study Overview

Detailed Description

Ultrasound has a significant role in recent anesthesia. It plays a significant role in detecting diaphragmatic mobility and detecting phrenic nerve palsy after regional anesthesia . the common and standard technique for shoulder analgesia is interscalen block. but it has its own complications like phrenic nerve palsy.

to bypass this complications ,several ways had been tried to overcome this complications.

in this study, the investigator compare between the standard interscalen block with distal blocks like infraclavicular subomohyoid block and subomohyoid subscapularis blocks according to diaghragm affection , duration of analgesia , side effects occured with blocks.

For infraclavicular subomohyoid block, the infraclavicular approach targets the posterior and lateral cords, thus anesthetizing the axillary nerve (which supplies the anterior and posterior shoulder joint), whereas the suprascapular nerve block done by blocking subomohyoid muscle anesthetizes the posterior shoulder.

For subscapularis subomohyoid block, subscapularis is done before subomohyoid block. Subscapularis block target subscapular nerve which arise from posterior cord and present on ventral surface of subscapularis muscle .

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sharqia Province
      • Zagazig, Sharqia Province, Egypt, 44519
        • Emad Hamdy Mohamed Morsy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient acceptance.
  • ASA I and ASA II.
  • Age 21-60 years old.
  • Both gender.
  • BMI < 35 Kg/m2.
  • Accepted mental state of the patient.
  • Elective Unilateral upper limb surgeries at the level of the shoulder.
  • Time of surgery less than 2 hours

Exclusion Criteria:

  • - Patient refusal.
  • Peripheral neuropathy.
  • Pathological coagulopathy.
  • Infection at the injection site.
  • Untreated pneumothorax.
  • Disturbed conscious level.
  • An allergy to local anesthetics used in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: interscalen group

(29) patients will receive an interscalene block before induction of general anaesthesia.

Patients will receive 20 ml of bupivacaine 0.25 %+250 mg of magnesium sulphate.

the participant will assess diaphragm sparing in each block and evaluate effectiveness of infraclavicular subomohyoid blocks and subomohyoid subscapularis blocks according to intraoperative and postoperative analgesia and diaphragm affection and comparing them with interscalen and with each others
Active Comparator: subomohyoid infracavicular group
(29) patients will receive subomohyoid infraclavicular block before induction of general anesthesia. Patients will receive 20 ml of bupivacaine 0.25 %+250 mg of magnesium sulphate.
the participant will assess diaphragm sparing in each block and evaluate effectiveness of infraclavicular subomohyoid blocks and subomohyoid subscapularis blocks according to intraoperative and postoperative analgesia and diaphragm affection and comparing them with interscalen and with each others
Active Comparator: subomohyoid subscapularis group
(29) patients will receive subomohyoid subscapularis block before induction of general anesthesia. Patients will receive 20 mL of 0.25% bupivacaine + 250 mg of magnesium sulfate.
the participant will assess diaphragm sparing in each block and evaluate effectiveness of infraclavicular subomohyoid blocks and subomohyoid subscapularis blocks according to intraoperative and postoperative analgesia and diaphragm affection and comparing them with interscalen and with each others

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change is being assessed (Diaphragm excursion)
Time Frame: basal preoperatively , immediately postoperatively in the pacu and 6 hours postoperatively
As shown before diaphragm excursion will be examined preoperative as basal measurement, immediately postoperative in the PACU and 6 hours postoperatively to detect diaghragm excursion.If ratio of post to pre-block is < 25% this means that phrenic nerve block is included.
basal preoperatively , immediately postoperatively in the pacu and 6 hours postoperatively
Thickness fraction
Time Frame: basal preoperatively, immediately postoperatively in the PACU, and 6 hours postoperatively
The percentage change in thickness between end expiration and peak inspiration. It was calculated as follows: (thickness at peak inspiration - thickness at end expiration/thickness at end expiration) ×100.
basal preoperatively, immediately postoperatively in the PACU, and 6 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative complication of the studied groups
Time Frame: 24 hours
the investigator will record patients with complications from the blocks like hypoxemia with saturation <90% , bradycardia with heart rate <50, nausea and vomiting
24 hours
Visual Analogue Scale (VAS) at different intervals within and between the studied groups
Time Frame: immediately postoperative in the PACU , 6 hours postoperatively up to 24 hour postoperatively
The investigators ask the patient to estimate the degree of pain on a scale from 1 to 10 and ask the patient to report the degree of pain from 0 to 10, with 0 no pain to 10 worst pain.
immediately postoperative in the PACU , 6 hours postoperatively up to 24 hour postoperatively
Total pethidine consumption in 24 hours of the studied groups
Time Frame: 24 hours
The investigator will calculate the total amount of pethidine consumed over a 24-hour period.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2023

Primary Completion (Actual)

December 20, 2023

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

May 14, 2023

First Submitted That Met QC Criteria

June 16, 2023

First Posted (Actual)

June 27, 2023

Study Record Updates

Last Update Posted (Estimated)

January 2, 2026

Last Update Submitted That Met QC Criteria

December 26, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • #6024/5-4-2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

planned after completion of the study

IPD Sharing Time Frame

after puplication of the study

IPD Sharing Access Criteria

contact of principal investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Surgeries Operations

Clinical Trials on diaghragm affection by ultrasound before and after the blocks

Subscribe